tiprankstipranks
Synthetic Biologics Inc (SYN)
NYSE MKT:SYN
Holding SYN?
Track your performance easily

Synthetic Biologics (SYN) Income Statement

0 Followers

Synthetic Biologics Income Statement

Last quarter (Q ), Synthetic Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Synthetic Biologics's net income was $-4.97M. See Synthetic Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 17.78M$ 14.27M$ 10.16M$ 15.66M$ 17.57M$ 26.25M
Operating Income
$ -17.78M$ -14.27M$ -10.16M$ -15.66M$ -17.57M$ -26.25M
Net Non Operating Interest Income Expense
$ 32.00K$ 6.00K$ 44.00K$ 283.00K$ 67.00K$ 21.00K
Other Income Expense
$ -32.00K---$ 4.08M$ 10.74M
Pretax Income
$ -17.78M$ -14.27M$ -10.12M$ -15.38M$ -13.42M$ -15.49M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -17.78M$ -23.19M$ -12.56M$ -16.08M$ -25.29M$ -22.14M
Basic EPS
$ -0.67$ -1.90$ -0.66$ -0.98$ -4.06$ -6.23
Diluted EPS
$ -0.67$ -1.90$ -0.66$ -0.98$ -4.06$ -6.23
Basic Average Shares
$ 293.86M$ 12.19M$ 19.01M$ 16.44M$ 6.23M$ 3.55M
Diluted Average Shares
$ 293.86M$ 12.19M$ 19.01M$ 16.44M$ 6.23M$ 3.55M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 17.78M$ 14.27M$ 10.16M$ 15.66M$ 17.57M$ 26.25M
Net Income From Continuing And Discontinued Operation
$ -17.78M$ -14.27M$ -10.04M$ -15.30M$ -13.37M$ -15.17M
Normalized Income
$ -17.75M$ -14.27M$ -10.04M$ -15.30M$ -17.45M$ -25.91M
Interest Expense
------
EBIT
$ -17.78M$ -14.27M$ -10.16M$ -15.66M$ -17.57M$ -26.25M
EBITDA
$ -17.71M$ -14.19M$ -9.96M$ -15.42M$ -17.30M$ -26.01M
Currency in USD

Synthetic Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis